Why the Dow's Flat This Morning

The stock market had a tough time Friday trying to parse through conflicting news. Oil prices fell after Saudi Arabia denied reports of a pipeline explosion, while Spain announced a higher government budget deficit than had been expected. But the IPO of Yelp went well, as shares of the online opinion guide company soared 60% from its offering price. Just after 10:45 a.m. EST, the Dow Jones Industrials (INDEX: ^DJI  ) were down just eight points at 12,972, while the S&P 500 (INDEX: ^GSPC  ) dropped two points to 1,372.

Travelers (NYSE: TRV  ) was the biggest loser in the Dow early, falling almost 1% despite having won a favorable ruling in a court case yesterday. A judge reversed a previous order that would have forced Travelers to pay more than $500 million toward asbestos claims against Johns-Manville, which was the largest maker of asbestos-containing products for nearly 50 years in the mid-20th century.

JPMorgan Chase (NYSE: JPM  ) was roughly unchanged. A report from Reuters highlighted the company's outperformance in the commodities industry, citing sales figures that came in well ahead of its fellow Wall Street trading firms. Commodity revenue made up more than 25% of what it calls "principal transactions," and continuing strength in the sector could help differentiate the bank from its competition.

Finally, Pfizer (NYSE: PFE  ) was down slightly in early trading. The company is selling its infant nutrition business, with bids due on Monday. World consumer giant Nestle is expected to bid against Mead Johnson and Danone for the business.

Look beyond the Dow for the most promising stocks. Learn about the one stock the Fool's chief investment officer picked to crush the market in this free report: "The Motley Fool's Top Stock for 2012." Instant access is just a click away.

Fool contributor Dan Caplinger doesn't own shares of the companies mentioned. You can follow him on Twitter here. The Motley Fool owns shares of JPMorgan Chase. Motley Fool newsletter services have recommended buying shares of Pfizer. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Fool has a disclosure policy.


Read/Post Comments (0) | Recommend This Article (6)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1799311, ~/Articles/ArticleHandler.aspx, 10/25/2014 12:00:44 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement